Exploring the in-situ evolution of Nitrofurantoin resistance in clinically derived Uropathogenic Escherichia coli isolates.
M. Vallee, C. Harding, J. Hall, P. D. Aldridge, A. Tan
This study investigates the in situ evolution of Nitrofurantoin resistance in uropathogenic E. coli isolates from two UTI patients, finding no fitness advantage for resistant strains but a selective advantage at sub-MIC concentrations.
bioRxiv · Jul 19, 2022Microbiology